601 related articles for article (PubMed ID: 38248857)
1. Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review.
Demicheva E; Dordiuk V; Polanco Espino F; Ushenin K; Aboushanab S; Shevyrin V; Buhler A; Mukhlynina E; Solovyova O; Danilova I; Kovaleva E
Metabolites; 2024 Jan; 14(1):. PubMed ID: 38248857
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatography-mass spectrometric multiple reaction monitoring-based strategies for expanding targeted profiling towards quantitative metabolomics.
Guo B; Chen B; Liu A; Zhu W; Yao S
Curr Drug Metab; 2012 Nov; 13(9):1226-43. PubMed ID: 22519369
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in lipidomics: Analytical and clinical perspectives.
Sethi S; Brietzke E
Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():8-16. PubMed ID: 28039059
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of metabolomics and proteomics based on capillary electrophoresis-mass spectrometry].
Wang F; Wang S; Cong H; Yu B
Se Pu; 2020 Sep; 38(9):1013-1021. PubMed ID: 34213267
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
7. [Recent advances in chemical derivatization-based chromatography-mass spectrometry methods for analysis of aldehyde biomarkers].
Zhu S; Zhao XE; Liu H
Se Pu; 2021 Aug; 39(8):845-854. PubMed ID: 34212585
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
Zhang A; Sun H; Yan G; Wang P; Wang X
Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in using mass spectrometry for mitochondrial metabolomics and lipidomics - A review.
Liu X; Xu G
Anal Chim Acta; 2018 Dec; 1037():3-12. PubMed ID: 30292306
[TBL] [Abstract][Full Text] [Related]
10. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
Zhao YY; Cheng XL; Lin RC
Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
[TBL] [Abstract][Full Text] [Related]
11. Advances in mass spectrometry-based multi-scale metabolomic methodologies and their applications in biological and clinical investigations.
Wang Z; Zhu H; Xiong W
Sci Bull (Beijing); 2023 Oct; 68(19):2268-2284. PubMed ID: 37666722
[TBL] [Abstract][Full Text] [Related]
12. Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders.
Sethi S; Hayashi MA; Sussulini A; Tasic L; Brietzke E
World J Biol Psychiatry; 2017 Oct; 18(7):506-520. PubMed ID: 26555297
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics and health: from nutritional crops and plant-based pharmaceuticals to profiling of human biofluids.
Marchev AS; Vasileva LV; Amirova KM; Savova MS; Balcheva-Sivenova ZP; Georgiev MI
Cell Mol Life Sci; 2021 Oct; 78(19-20):6487-6503. PubMed ID: 34410445
[TBL] [Abstract][Full Text] [Related]
14. Integration of GC-MS and LC-MS for untargeted metabolomics profiling.
Zeki ÖC; Eylem CC; Reçber T; Kır S; Nemutlu E
J Pharm Biomed Anal; 2020 Oct; 190():113509. PubMed ID: 32814263
[TBL] [Abstract][Full Text] [Related]
15. Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases.
Sarkar S; Roy D; Chatterjee B; Ghosh R
Metabolomics; 2024 Mar; 20(2):37. PubMed ID: 38459207
[TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
Mahmud I; Garrett TJ
J Am Soc Mass Spectrom; 2020 Oct; 31(10):2013-2024. PubMed ID: 32880453
[TBL] [Abstract][Full Text] [Related]
17. Application of gas chromatography-mass spectrometry-based metabolomics in food science and technology.
Putri SP; Ikram MMM; Sato A; Dahlan HA; Rahmawati D; Ohto Y; Fukusaki E
J Biosci Bioeng; 2022 May; 133(5):425-435. PubMed ID: 35184928
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics and lipidomics strategies in modern drug discovery and development.
Astarita G; Kelly RS; Lasky-Su J
Drug Discov Today; 2023 Oct; 28(10):103751. PubMed ID: 37640150
[TBL] [Abstract][Full Text] [Related]
19. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
